$BNTX NEXT BREAKOUT TOMORROW - Ascending TriangleBiontechs future is bright and the chart looks like it want´s to break out this week!
22UA trade ideas
Bntx Short it Rallied last 2weeks on news of UK purchasing extra vaccines . Could be profit taking. ow that the deal is certified or the old "Buy the rumor, sell the news". Over bought on every indicator, now the only thing left is wait for it to break the trendline for reversal conformation.
Trendline break 160
Entry 159
BNTX probably going to the down side this weekNASDAQ:BNTX
After huge uptrend with 11 green bars, finally the stock created the first red bar.
RSI14 now around 85!
If BNTX show at monday sign of downtrend, I will happy to join this round..
Also in this position we have a very good risk-reward ratio.
BNTX (BioNTech) - Bullish end to quarterBioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.
Analysis/Commentary
Strong EPS and Sales Growth Y-on-Y
Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Current quarter has given stronf price move above anticipated LOW point
- Still plenty more room for a move to MID point and beyond before quarter end
- Trailing stop-loss on price above MID point
GOOD LUCK.
DO YOUR OWN RESEARCH!
$BNTX with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BNTX after a Positive under reaction following its earnings release placing the stock in drift A
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
Bntx update. Longer view. We can expect a big move in next few wOnly good news coming out of BNTX. Today came 100% effectiveness in 12-15 year olds. When Marburg facility comes online they will be making bank on 50% share with Pfizer. Targeting 128 Pfizer entry, then a push 150+ before a pullback
Positions: 400 shares, 120/130c May, 150/160c June Lottos.
BNTX pennant formationTailwinds of vaccine sales, cancer therapy trials based off their mrna technique that they have used to great success with Pfizer.
Remember, Pfizer has invested in this at 128 a share.
Symmetrical Triangle? A symmetrical triangle can break either way, up or down.
A break of 94.80 could signal a move down.
Not a recommendation.
If price stops at the .786, this could be a gartley pattern which would be bullish. If it drops below the .786, will be a farther drop of course. I am not gonna hold my breath though. (o:
Looks a bit too risky to go long on this one right now.
A symmetrical triangle needs 5 touches to be valid. 2 touches to one trndline and 3 to the other. sometimes the 5th touch can determine direction but price can hang inside for a while without breaking up or down. It is a consolidation pattern and direction to be determined. The top trendline is resistance and the bottom is support until price (the market) decides which way this to go.
$BNTX Cup n HandleNASDAQ:BNTX
CHART
Weekly Cup n Handle
Pivot $120.99
Length 12 wks
Depth 35%
Handle 25%
Daily RSI Bullish Divergence
Daily Stochastic Crossover under 20
RS Rating 84
FUNDAMENTALS
EPS Rating 4
Group RS Rating 58
SMR Rating D
Acc/Dis Rating B
Composite Rating 41
Timeliness Rating C
Sponsorship Rating A
$BNTX PT 300 and higher$PFE and $BNTX Partnership
Pfizer Is Ready, Even For COVID-19 Variants
This week is all about healthcare with Pfizer Inc. (NYSE: PFE), Sanofi SA (NASDAQ: SNY), Regeneron Pharmaceticals Inc (NASDAQ: REGN), and Bristol-Myers Squibb Co (NYSE: BMY) reporting earnings. But, what is under the spotlight is the effort pharmaceutical and biotech companies are making to combat COVID-19 or more precisely, the vaccine. Pfizer was the first who brought it to the market and gained FDA approval along with using the ground-breaking mRNA technology successfully.
Pfizer's Scientific Success
